Oxazepam


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000236 Adenoma PMID:9538042
MESH:D000686 Amyloidosis PMID:7982536
MESH:D001008 Anxiety Disorders PMID:7769598
MESH:D003128 Coma PMID:19109207
MESH:D003328 Coronary Thrombosis PMID:16048847
MESH:D005221 Fatigue PMID:11488371; PMID:16182353
MESH:D006130 Growth Disorders PMID:3936103
MESH:D006528 Carcinoma, Hepatocellular PMID:21147764; PMID:7982536; PMID:8200073
MESH:D006529 Hepatomegaly PMID:3698206; PMID:9538042
MESH:D006965 Hyperplasia PMID:7982536; PMID:9538042
MESH:D006984 Hypertrophy PMID:12727805
MESH:D007680 Kidney Neoplasms PMID:9538042
MESH:D007859 Learning Disabilities PMID:3936103
MESH:D008113 Liver Neoplasms PMID:10467420
MESH:D008114 Liver Neoplasms, Experimental PMID:12727805; PMID:3698206; PMID:7982536; PMID:8200073
MESH:D011297 Prenatal Exposure Delayed Effects PMID:1646381; PMID:3936103
MESH:D013009 Somnambulism PMID:453369
MESH:D013276 Stomach Ulcer PMID:9538042
MESH:D013375 Substance Withdrawal Syndrome PMID:3365642; PMID:6418370; PMID:6806585; PMID:6810073; PMID:6871816; PMID:7132871
MESH:D013964 Thyroid Neoplasms PMID:7982536
MESH:D016757 Death, Sudden, Cardiac PMID:12547310
MESH:D018197 Hepatoblastoma PMID:7982536
MESH:D018248 Adenoma, Liver Cell PMID:21147764; PMID:7982536; PMID:8200073
MESH:D019954 Neurobehavioral Manifestations PMID:1646381
MESH:D064420 Drug-Related Side Effects and Adverse Reactions PMID:9538042

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.